PATENT CLAIM ANALYSIS

Application Number: 15986382
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-S100A9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-S100A9 antibody are also provided.

Claim (Index 36):
The method of  claim 21 , wherein the anti-S100A9 antibody is administered to the subject at least 24 hours prior to exposure to the pathogen.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.43333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14985591', '15323858', '14006854', '13700037', '13047385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7412753033087777
- 35 USC 102 Novelty (BERT): 0.6148375778098545
- Combined Prediction Score: 0.7286315307588854
- Mean Citation Score: 345.32750000000016
- Max Citation Score: 685.1055
- Similarity Product: 466.8142683824301

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test